activity
20172025
most citedAnnealed Generative Adversarial Networks

9 citations · 32 across the 14 of their papers we have counts for

collaborators

24 papers

q-bio.GN20251 cited

Multi-megabase scale genome interpretation with genetic language models

Frederik Träuble, Lachlan Stuart, Andreas Georgiou +9

Understanding how molecular changes caused by genetic variation drive disease risk is crucial for deciphering disease mechanisms. However, interpreting genome sequences is challeng…

cs.LG20223 cited

From Points to Functions: Infinite-dimensional Representations in Diffusion Models

Sarthak Mittal, Guillaume Lajoie, Stefan Bauer +1

Diffusion-based generative models learn to iteratively transfer unstructured noise to a complex target distribution as opposed to Generative Adversarial Networks (GANs) or the deco…

cs.LG20223 cited

Federated Learning in Multi-Center Critical Care Research: A Systematic Case Study using the eICU Database

Arash Mehrjou, Ashkan Soleymani, Annika Buchholz +3

Federated learning (FL) has been proposed as a method to train a model on different units without exchanging data. This offers great opportunities in the healthcare sector, where l…

cs.RO2022

Physical Derivatives: Computing policy gradients by physical forward-propagation

Arash Mehrjou, Ashkan Soleymani, Stefan Bauer +1

Model-free and model-based reinforcement learning are two ends of a spectrum. Learning a good policy without a dynamic model can be prohibitively expensive. Learning the dynamic mo…

cs.LG2021

GalilAI: Out-of-Task Distribution Detection using Causal Active Experimentation for Safe Transfer RL

Sumedh A Sontakke, Stephen Iota, Zizhao Hu +3

Out-of-distribution (OOD) detection is a well-studied topic in supervised learning. Extending the successes in supervised learning methods to the reinforcement learning (RL) settin…

cs.LG20218 cited

GeneDisco: A Benchmark for Experimental Design in Drug Discovery

Arash Mehrjou, Ashkan Soleymani, Andrew Jesson +4

In vitro cellular experimentation with genetic interventions, using for example CRISPR technologies, is an essential step in early-stage drug discovery and target validation that s…